Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naïve with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating
Eficiency of Different Doses of Rituximab in Rheumatoid Arthritis | Reumatología Clínica
Arthritis News: Lower Dose of Rituximab for RA Treatment Explored
RA | RITUXAN® (rituximab) Dosing Overview for Rheumatoid Arthritis
Ultra-Low Dose of Rituximab Safely Eases Rheumatoid Arthritis Over Long Term: Study - Consumer Health News | HealthDay
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial - The Lancet
Rituximab protocols | Download Table
Should You Get the COVID-19 Vaccine If You Take Rituximab?
RA | RITUXAN® (rituximab) Infusion Steps & Resources
Drug Insight: the mechanism of action of rituximab in autoimmune disease—the immune complex decoy hypothesis | Nature Reviews Rheumatology
RA | RITUXAN® (rituximab) Dosing Overview for Rheumatoid Arthritis
ePosters - A retrospective audit of reduced-dose rituximab in rheumatoid arthritis
Rheumatoid arthritis patients initiating rituximab with low number of previous bDMARDs failures may effectively reduce rituximab dose and experience fewer serious adverse events than patients on full dose: a 5-year cohort study
Efficacy of Rituximab for Pemphigus: A Systematic Review and Meta-analysis of Different Regimens | HTML | Acta Dermato-Venereologica
Ultra-Low Rituximab Dose in RA Fails to Meet Non-Inferiority
PV | RITUXAN® (rituximab) Dosing & Infusion Resources
Ultra-low doses of rituximab for continued treatment of rheumatoid arthritis (REDO study): a randomised controlled non-inferiority trial - The Lancet Rheumatology
GPA & MPA | Taking & Dosing RITUXAN® (rituximab)
Protocol of rituximab dosing and administration. | Download Scientific Diagram
Algorithm for the use of rituximab in patients with RA. Broken line... | Download Scientific Diagram
Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial | Nature Medicine
RA | RITUXAN® (rituximab) Infusions & Dosing Schedule
PDF) Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: Data from the CERERRA collaboration
Rituxan (Rituximab): Uses, Dosage, Side Effects, Interactions, Warning
GPA & MPA | RITUXAN® (rituximab) Pediatric Dosing & Infusion Info
